Clinical Trial Update: Myeloma Registry Platform (MYRIAM)

View source ↗

Summary

A clinical trial entry for the Myeloma Registry Platform (MYRIAM) sponsored by iOMEDICO AG, currently recruiting participants with multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: iOMEDICO AG | Conditions: Multiple Myeloma | Status: RECRUITING